In our study, we show that IRE1α plays an important role in stellate cell – tumor cell interactions and that pharmacological inhibition of IRE1α-endoribonuclease activity slows down the progression of HCC in vivo. This evidence concerns the gene ERN1 and hepatocellular carcinoma.